Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-258,408
Closed -$8.49M 351
2015
Q3
$8.49M Buy
+258,408
New +$8.69M 0.19% 70
2015
Q2
Sell
-258,713
Closed -$9.06M 434
2015
Q1
$9.06M Sell
258,713
-4,475
-2% -$158K 0.12% 76
2014
Q4
$10M Buy
263,188
+38,291
+17% +$1.4M 0.09% 72
2014
Q3
$7.98M Buy
224,897
+80,240
+55% +$2.98M 0.07% 104
2014
Q2
$5.65M Sell
144,657
-79,346
-35% -$2.96M 0.24% 123
2014
Q1
$8.16M Buy
224,003
+191,662
+593% +$6.99M 0.36% 92
2013
Q4
$1.12M Sell
32,341
-55,425
-63% -$1.78M 0.03% 408
2013
Q3
$2.45M Buy
87,766
+26,346
+43% +$702K 0.07% 227
2013
Q2
$1.66M Buy
+61,420
New +$1.7M 0.02% 372

Other funds holding XYL

NatWest Group's XYL Position: Q4 2015 in Review

NatWest Group sold out of Xylem (XYL) in Q4 2015, closing a stake of 258,408 shares — an estimated $8.49M sold.

NatWest Group first reported a position in XYL in Q2 2013 and held it in 9 quarters. The position peaked at $10M in Q4 2014. 443 funds tracked by Wall St. Rank hold XYL as of Q4 2015.

  • NatWest Group reported no remaining Xylem position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 258,408 Xylem shares in Q4 2015, an estimated $8.49M.
  • NatWest Group first reported a position in Xylem in Q2 2013 and held it in 9 quarters.
  • NatWest Group's Xylem position peaked at $10M in Q4 2014.
  • 443 funds tracked by Wall St. Rank held Xylem as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.